Glen De Vries is an American businessman and entrepreneur who is best known for being the co-founder and president of Medidata Solutions, a global provider of cloud-based clinical trial management systems. He has been credited with revolutionizing the way clinical trials are conducted by introducing innovative digital technologies. In this article, we will take a look at Glen De Vries’ net worth, biography, wiki, age, and height.
Net Worth of Glen De Vries
Glen De Vries’ net worth is estimated to be around $550 million. He has earned his wealth from his career as a businessman and entrepreneur. He is the co-founder and president of Medidata Solutions, a global provider of cloud-based clinical trial management systems. The company is publicly traded on the NASDAQ and has a market cap of over $6 billion. He also owns a number of other companies, including Medidata Solutions Japan, Medidata Solutions Korea, and Medidata Solutions Europe.
Biography of Glen De Vries
Glen De Vries was born in New York City in 1958. He attended the University of Pennsylvania, where he earned a bachelor’s degree in economics. After graduation, he worked for a number of different companies, including Oracle and Deloitte Consulting. In 1999, he founded Medidata Solutions with Tarek Sherif. Since then, the company has grown to become a leader in the clinical trial management industry, with offices in over 20 countries around the world.
Wiki of Glen De Vries
Glen De Vries is the co-founder and president of Medidata Solutions. He is also the co-founder and chairman of the board of directors for Medidata Japan, Medidata Korea, and Medidata Europe. He is a member of the board of directors of the Society for Clinical Data Management, and is a board member of the American Institute for Medical and Biological Engineering.
Age and Height of Glen De Vries
Glen De Vries is 62 years old as of 2021. He is 6 feet tall (183 cm).
Glen De Vries is a successful businessman and entrepreneur who has revolutionized the way clinical trials are conducted. He has earned his wealth from his career and is estimated to have a net worth of around $550 million. He is also a board member of several organizations and is actively involved in the clinical trial management industry.
